• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

詹姆斯·布莱克爵士与普萘洛尔。基础科学在心血管药理学史上的作用。

Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology.

作者信息

Stapleton M P

机构信息

Faculty of Medicine, University of Calgary, AB, Canada.

出版信息

Tex Heart Inst J. 1997;24(4):336-42.

PMID:9456487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC325477/
Abstract

The history of cardiology encompasses some of the most revered names in medical history, many belonging to physicians who have advanced knowledge beyond their time. However, there have been countless others whose work in the basic sciences has paid large dividends to clinical cardiology. The original example of such an individual is William Harvey, whose reasoned experimentation led to the understanding of the circulation of blood. Another such man, Sir James Black, has contributed to basic scientific and clinical knowledge in cardiology, both as a physician and as a basic scientist. His invention of propranolol, the beta adrenergic receptor antagonist that revolutionized the medical management of angina pectoris, is considered to be one of the most important contributions to clinical medicine and pharmacology of the 20th century. His method of research, his discoveries about adrenergic pharmacology, and his clarification of the mechanisms of cardiac action are all strengths of his work. In 1988, he was awarded the Nobel Prize in Medicine. Sir James's conclusions and method of research have continued to influence work in clinical pharmacology and cardiovascular medicine. Thus, the development of propranolol runs parallel to most other great achievements in medicine: the genius of a few builds on the accomplishments of many, and the discovery influences thinking long after the breakthrough has occurred.

摘要

心脏病学的历史涵盖了医学史上一些最受尊崇的人物,其中许多人是超越其时代推进知识的内科医生。然而,还有无数其他人在基础科学方面的工作为临床心脏病学带来了巨大回报。这样一个人的典型例子是威廉·哈维,他经过合理的实验,使人们对血液循环有了认识。另一个这样的人是詹姆斯·布莱克爵士,他作为内科医生和基础科学家,都为心脏病学的基础科学和临床知识做出了贡献。他发明的普萘洛尔,即β肾上腺素能受体拮抗剂,彻底改变了心绞痛的药物治疗,被认为是20世纪临床医学和药理学最重要的贡献之一。他的研究方法、他对肾上腺素能药理学的发现以及他对心脏作用机制的阐明都是他工作的优点。1988年,他被授予诺贝尔医学奖。詹姆斯爵士的结论和研究方法继续影响着临床药理学和心血管医学的工作。因此,普萘洛尔的发展与医学上大多数其他伟大成就并行:少数天才建立在许多人的成就之上,而且这一发现的影响在突破发生很久之后仍在影响着人们的思维。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe5/325477/96cb0afdf56e/thij00027-0107-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe5/325477/96cb0afdf56e/thij00027-0107-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fe5/325477/96cb0afdf56e/thij00027-0107-a.jpg

相似文献

1
Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology.詹姆斯·布莱克爵士与普萘洛尔。基础科学在心血管药理学史上的作用。
Tex Heart Inst J. 1997;24(4):336-42.
2
Sir James Black (1924-2010), β-blockers and liver disease.詹姆斯·布莱克爵士(1924 - 2010),β受体阻滞剂与肝脏疾病。
Gastroenterol Clin Biol. 2010 Oct;34(10):513-5. doi: 10.1016/j.gcb.2010.05.009. Epub 2010 Oct 12.
3
The major impacts of James Black's drug discoveries on medicine and pharmacology.詹姆斯·布莱克的药物发现对医学和药理学的主要影响。
Trends Pharmacol Sci. 2011 Apr;32(4):183-8. doi: 10.1016/j.tips.2011.02.001. Epub 2011 Mar 15.
4
Pioneers in cardiology: Sir James Black, MB, ChB, FRS, FRCP. Interview by Mark Nicholls.心脏病学先驱:詹姆斯·布莱克爵士,医学学士、外科学士、皇家学会会员、皇家内科医师学会会员。马克·尼科尔斯访谈
Circulation. 2008 Feb 26;117(8):f47-8.
5
[Remarks on angina pectoris].[关于心绞痛的论述]
Monaldi Arch Chest Dis. 2005 Mar;64(1):67-71. doi: 10.4081/monaldi.2005.617.
6
History of cardiology: Sir Thomas Brunton, MD.心脏病学历史:医学博士托马斯·布伦顿爵士
Circulation. 2006 Oct 17;114(16):f164.
7
[Introduction of adrenergic beta-blockers into medical therapy].[肾上腺素能β受体阻滞剂引入医学治疗]
Srp Arh Celok Lek. 1992 Jun;120 Suppl 4:1-4.
8
Pharmacology at the Jagiellonian University in Kracow, short review of contribution to global science and cardiovascular research through 400 years of history.克拉科夫雅盖隆大学的药理学,对其400年历史中对全球科学和心血管研究贡献的简要回顾。
J Physiol Pharmacol. 2006 Apr;57 Suppl 1:119-36.
9
The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.保罗·埃尔利希对药理学的贡献:在其诺贝尔奖获奖一百周年之际的致敬。
Pharmacology. 2008;82(3):171-9. doi: 10.1159/000149583. Epub 2008 Aug 5.
10
A story of heartache: the understanding of angina pectoris in the pre-surgical period.一个心痛的故事:术前阶段对心绞痛的认识。
J R Coll Physicians Edinb. 2011 Dec;41(4):361-5. doi: 10.4997/JRCPE.2011.416.

引用本文的文献

1
Selected Medicines That Can Cause Cardiac Arrest with Asystole.可导致心搏骤停伴心搏停止的特定药物。
Curr Issues Mol Biol. 2025 Apr 24;47(5):299. doi: 10.3390/cimb47050299.
2
Evolving Strategies for Use of Phytochemicals in Prevention and Long-Term Management of Cardiovascular Diseases (CVD).植物化学物质在心血管疾病(CVD)预防和长期管理中的应用策略的发展。
Int J Mol Sci. 2024 Jun 4;25(11):6176. doi: 10.3390/ijms25116176.
3
History of the liver-heart relationship.肝心关系的历史。

本文引用的文献

1
Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide).一种β-肾上腺素能阻滞剂(奈他洛尔)的临床药理学
Lancet. 1962 Aug 18;2(7251):314-6. doi: 10.1016/s0140-6736(62)90104-6.
2
Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide).一种新型肾上腺素能β受体阻滞剂化合物(奈他洛尔)的药理学
Lancet. 1962 Aug 18;2(7251):311-4. doi: 10.1016/s0140-6736(62)90103-4.
3
Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol.异丙肾上腺素的二氯类似物对抑制性肾上腺素能受体的阻断作用。
Clin Liver Dis (Hoboken). 2024 Apr 26;23(1):e0151. doi: 10.1097/CLD.0000000000000151. eCollection 2024 Jan-Jun.
4
3-Nitroatenolol: First Synthesis, Chiral Resolution and Enantiomers' Absolute Configuration.3-硝基阿替洛尔:首次合成、手性拆分及对映体的绝对构型
Molecules. 2024 Apr 3;29(7):1598. doi: 10.3390/molecules29071598.
5
Neuroendocrine mechanism of gastric acid secretion: Historical perspectives and recent developments in physiology and pharmacology.胃酸分泌的神经内分泌机制:生理学和药理学的历史观点和最新进展。
J Neuroendocrinol. 2023 Nov;35(11):e13305. doi: 10.1111/jne.13305. Epub 2023 Jun 15.
6
Beta-blockers in cardiac arrhythmias-Clinical pharmacologist's point of view.β受体阻滞剂在心律失常中的应用——临床药理学家的观点
Front Pharmacol. 2023 Jan 9;13:1043714. doi: 10.3389/fphar.2022.1043714. eCollection 2022.
7
Caged-carvedilol as a new tool for visible-light photopharmacology of β-adrenoceptors in native tissues.笼状卡维地洛作为天然组织中β-肾上腺素能受体可见光光药理学的新工具。
iScience. 2022 Sep 13;25(10):105128. doi: 10.1016/j.isci.2022.105128. eCollection 2022 Oct 21.
8
Seizures and Irreversible Cardiogenic Shock Following Propranolol Poisoning: Report of 2 Cases and Literature Review.普萘洛尔中毒后癫痫发作与不可逆性心源性休克:2例报告及文献复习
Clin Med Insights Case Rep. 2022 Sep 23;15:11795476221126981. doi: 10.1177/11795476221126981. eCollection 2022.
9
Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies.普萘洛尔:良性肿瘤与癌症治疗中的“挡拆配合”团队成员
J Clin Med. 2022 Aug 4;11(15):4539. doi: 10.3390/jcm11154539.
10
A Photoswitchable Ligand Targeting the β -Adrenoceptor Enables Light-Control of the Cardiac Rhythm.一种光致变色配体靶向β-肾上腺素能受体,实现心脏节律的光控。
Angew Chem Int Ed Engl. 2022 Jul 25;61(30):e202203449. doi: 10.1002/anie.202203449. Epub 2022 Jun 9.
J Pharmacol Exp Ther. 1958 Apr;122(4):480-8.
4
A personal view of pharmacology.药理学之我见。
Annu Rev Pharmacol Toxicol. 1996;36:1-33. doi: 10.1146/annurev.pa.36.040196.000245.
5
The history of cardiology--is it important today?心脏病学的历史——在当今重要吗?
Clin Cardiol. 1995 Jul;18(7):367-9. doi: 10.1002/clc.4960180703.
6
Adrenergic receptors: a personal and practical view.肾上腺素能受体:个人见解与实用观点
Perspect Biol Med. 1973 Autumn;17(1):119-22. doi: 10.1353/pbm.1973.0047.
7
Medical history and the cardiologist.病史与心脏病专家。
Int J Cardiol. 1988 Apr;19(1):1-4. doi: 10.1016/0167-5273(88)90183-0.
8
Drugs from emasculated hormones: the principle of syntopic antagonism.来自阉割激素的药物:同位拮抗原理。
Science. 1989 Aug 4;245(4917):486-93. doi: 10.1126/science.2569237.
9
Propranolol in the treatment of angina: a review.普萘洛尔治疗心绞痛的综述
Postgrad Med J. 1976;52 Suppl 4:35-41.
10
Effect of propranolol on mortality in patients with angina.普萘洛尔对心绞痛患者死亡率的影响。
Postgrad Med J. 1976;52 Suppl 4(603):57-60.